Jaskowiak NT - Search Results

1

Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance.

Gupta VK, Jaskowiak NT, Beckett MA, Mauceri HJ, Grunstein J, Johnson RS, Calvin DA, Nodzenski E, Pejovic M, Kufe DW, Posner MC, Weichselbaum RR. Gupta VK, et al. Among authors: jaskowiak nt. Cancer J. 2002 Jan-Feb;8(1):47-54. doi: 10.1097/00130404-200201000-00009. Cancer J. 2002. PMID: 11895203

2

Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.

Gorski DH, Beckett MA, Jaskowiak NT, Calvin DP, Mauceri HJ, Salloum RM, Seetharam S, Koons A, Hari DM, Kufe DW, Weichselbaum RR. Gorski DH, et al. Among authors: jaskowiak nt. Cancer Res. 1999 Jul 15;59(14):3374-8. Cancer Res. 1999. PMID: 10416597

3

Antitumor interaction of short-course endostatin and ionizing radiation.

Hanna NN, Seetharam S, Mauceri HJ, Beckett MA, Jaskowiak NT, Salloum RM, Hari D, Dhanabal M, Ramchandran R, Kalluri R, Sukhatme VP, Kufe DW, Weichselbaum RR. Hanna NN, et al. Among authors: jaskowiak nt. Cancer J. 2000 Sep-Oct;6(5):287-93. Cancer J. 2000. PMID: 11079167

4

NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity.

Salloum RM, Jaskowiak NT, Mauceri HJ, Seetharam S, Beckett MA, Koons AM, Hari DM, Gupta VK, Reimer C, Kalluri R, Posner MC, Hellman S, Kufe DW, Weichselbaum RR. Salloum RM, et al. Among authors: jaskowiak nt. Cancer Res. 2000 Dec 15;60(24):6958-63. Cancer Res. 2000. PMID: 11156396

5

Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma.

Gupta VK, Park JO, Jaskowiak NT, Mauceri HJ, Seetharam S, Weichselbaum RR, Posner MC. Gupta VK, et al. Among authors: jaskowiak nt. Ann Surg Oncol. 2002 Jun;9(5):500-4. doi: 10.1007/BF02557275. Ann Surg Oncol. 2002. PMID: 12052763

6

Selective gene expression using a DF3/MUC1 promoter in a human esophageal adenocarcinoma model.

Gupta VK, Park JO, Kurihara T, Koons A, Mauceri HJ, Jaskowiak NT, Kufe DW, Weichselbaum RR, Posner MC. Gupta VK, et al. Among authors: jaskowiak nt. Gene Ther. 2003 Feb;10(3):206-12. doi: 10.1038/sj.gt.3301867. Gene Ther. 2003. PMID: 12571627

7

Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.

Murphy KT, Wardak A, Beckett MA, Lopez CA, Mehta N, Kimchi E, Salloum RM, Jaskowiak NT, Posner MC, Ohno T, Kufe DW, Weichselbaum RR, Mauceri HJ. Murphy KT, et al. Among authors: jaskowiak nt. Cancer Chemother Pharmacol. 2005 Sep;56(3):317-21. doi: 10.1007/s00280-004-0986-8. Epub 2005 May 11. Cancer Chemother Pharmacol. 2005. PMID: 15887016

8

Validation of the RSClin risk calculator in the National Cancer Data Base.

Vannier AGL, Dhungana A, Zhao F, Chen N, Shubeck S, Hahn OM, Nanda R, Jaskowiak NT, Fleming GF, Olopade OI, Pearson AT, Huo D, Howard FM. Vannier AGL, et al. Among authors: jaskowiak nt. Cancer. 2024 Apr 15;130(8):1210-1220. doi: 10.1002/cncr.35163. Epub 2023 Dec 26. Cancer. 2024. PMID: 38146744

9

Adenocarcinoma at a strictureplasty site in Crohn's disease: report of a case.

Jaskowiak NT, Michelassi F. Jaskowiak NT, et al. Dis Colon Rectum. 2001 Feb;44(2):284-7. doi: 10.1007/BF02234306. Dis Colon Rectum. 2001. PMID: 11227948

10

Needle versus excisional biopsy for noninvasive and invasive breast cancer: report from the National Cancer Data Base, 2003-2008.

Williams RT, Yao K, Stewart AK, Winchester DJ, Turk M, Gorchow A, Jaskowiak N, Winchester DP. Williams RT, et al. Ann Surg Oncol. 2011 Dec;18(13):3802-10. doi: 10.1245/s10434-011-1808-y. Epub 2011 Jun 1. Ann Surg Oncol. 2011. PMID: 21630122

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters